NASDAQ:PIRS - Pieris Pharmaceuticals SEC Filings & 10K Form

$4.26
-0.01 (-0.23 %)
(As of 07/16/2019 10:01 AM ET)
Today's Range
$4.20
Now: $4.26
$4.3037
50-Day Range
$4.05
MA: $4.39
$4.70
52-Week Range
$2.39
Now: $4.26
$6.55
Volume35,443 shs
Average Volume292,604 shs
Market Capitalization$209.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.25

SEC Filings

Pieris Pharmaceuticals (NASDAQ:PIRS) SEC Filings

DateFilerForm TypeView
07/11/2019
9:32 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
06/18/2019
3:07 PM
Pieris Pharmaceuticals (Filer)
Form DEFA14A
View Filing
06/18/2019
3:05 PM
Pieris Pharmaceuticals (Filer)
Form DEF 14A
View Filing
06/17/2019
6:53 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/06/2019
7:38 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2019
1:34 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/16/2019
8:46 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/14/2019
3:50 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/14/2019
8:09 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/10/2019
3:02 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/10/2019
6:36 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2019
4:36 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/08/2019
7:38 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/02/2019
8:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/01/2019
7:58 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/18/2019
4:27 PM
Pieris Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/13/2019
9:34 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2019
6:18 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
1:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/04/2019
3:09 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/01/2019
10:57 AM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:46 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:45 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:42 PM
Pieris Pharmaceuticals (Issuer)
Prelack Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:40 PM
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:37 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:35 PM
BIZZARI JEAN-PIERRE (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:35 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2019
4:34 PM
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/07/2019
6:13 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/26/2018
5:32 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
11/19/2018
7:26 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/15/2018
7:54 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
11:32 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/07/2018
6:27 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/30/2018
3:34 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
4:11 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/25/2018
4:21 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/25/2018
4:19 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/25/2018
4:16 PM
Pieris Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/25/2018
7:31 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/02/2018
8:02 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/27/2018
3:43 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
09/19/2018
9:44 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/17/2018
4:42 PM
KIRITSY CHRISTOPHER P (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/17/2018
7:56 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/14/2018
4:31 PM
Kiener Peter A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/10/2018
7:56 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/05/2018
8:31 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/26/2018
11:15 PM
Pieris Pharmaceuticals (Filer)
Form EFFECT
View Filing
08/09/2018
3:43 PM
Pieris Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
08/09/2018
3:38 PM
Pieris Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
08/09/2018
3:03 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/09/2018
6:17 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
8:31 AM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
07/31/2018
3:51 PM
Pieris Pharmaceuticals (Filer)
Form 10-Q/A
View Filing
07/26/2018
4:20 PM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/26/2018
4:10 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2018
4:11 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
06/22/2018
3:01 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
06/14/2018
3:47 PM
Pieris Pharmaceuticals (Filer)
Form DEFA14A
View Filing
06/14/2018
3:44 PM
Pieris Pharmaceuticals (Filer)
Form DEF 14A
View Filing
06/06/2018
8:42 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2018
3:12 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
05/16/2018
8:08 AM
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2018
6:46 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/08/2018
7:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/02/2018
4:13 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP III LLC (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
3:51 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
05/01/2018
2:45 PM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/01/2018
2:44 PM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/01/2018
2:43 PM
Pieris Pharmaceuticals (Filer)
Form CT ORDER
View Filing
04/26/2018
5:14 PM
Pieris Pharmaceuticals (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
5:13 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/26/2018
5:01 PM
Barbier Ann (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/26/2018
6:49 AM
Pieris Pharmaceuticals (Filer)
Form 10-Q/A
View Filing
04/26/2018
5:56 AM
Pieris Pharmaceuticals (Filer)
Form 10-Q/A
View Filing
04/26/2018
5:19 AM
Pieris Pharmaceuticals (Filer)
Form 10-K/A
View Filing
04/25/2018
8:01 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/15/2018
3:00 PM
Pieris Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/13/2018
7:00 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/09/2018
5:06 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/26/2018
6:16 PM
Matis Louis (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2018
6:15 PM
Pieris Pharmaceuticals (Issuer)
Reine Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/26/2018
6:15 PM
Pieris Pharmaceuticals (Issuer)
Yoder Stephen S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/22/2018
7:32 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/21/2018
3:32 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
02/15/2018
3:57 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP III LLC (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
3:11 PM
Pieris Pharmaceuticals (Filer)
Form 424B5
View Filing
02/12/2018
2:23 PM
Pieris Pharmaceuticals (Subject)
Tekla Capital Management LLC (Filed by)
Form SC 13G/A
View Filing
02/09/2018
6:41 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/26/2018
10:51 AM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
01/25/2018
8:27 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
01/08/2018
6:36 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/05/2018
2:14 PM
ORBIMED ADVISORS LLC (Filed by)
Pieris Pharmaceuticals (Subject)
Form SC 13D/A
View Filing
01/04/2018
2:23 PM
ISALY SAMUEL D (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP III LLC (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2017
4:12 PM
ISALY SAMUEL D (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP III LLC (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2017
6:50 AM
Pieris Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2017
3:03 PM
GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel